AstraZeneca Evusheld approved in EU for treatment of COVID Ruchika Sharma20 Sept 2022 2:30 PM ISTThe recommended dose of Evusheld for treatment in Europe is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
Antibody combo of Tixagevimab and Cilgavimab effectively prevents COVID-19: NEJM Medha Baranwal23 April 2022 10:15 AM ISTUK: Single dose of AZD7442 (Tixagevimab-Cilgavimab) is effective for COVID-19 prevention sans any evident safety concerns. Further administration of...
AstraZeneca tixagevimab, cilgavimab cocktail shows positive result in Covid-19 trial MD Bureau12 Oct 2021 10:00 AM ISTLondon: AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on...
AstraZeneca seeks USFDA authorization for Covid-19 Prophylaxis drug AZD7442 Ruchika Sharma6 Oct 2021 2:13 PM ISTUK: AstraZeneca has submitted a request to the US Food and Drug Administration (USFDA) for an Emergency Use Authorization (EUA) for AZD7442, its...
AstraZeneca to supply 5 lakh extra doses of COVID-19 antibody cocktail to US Ruchika Sharma20 March 2021 2:37 PM ISTUK: AstraZeneca will supply up to half a million extra doses of its experimental antibody-based COVID-19 combination therapy to the United States, in...
COVID-19 Prevention: AstraZeneca begins trials on antibody cocktail Ruchika Sharma22 Nov 2020 9:30 AM ISTLondon: AstraZeneca started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be...
AstraZeneca, US strike deal for Covid-19 antibody treatment touted by Trump Ruchika Sharma11 Oct 2020 10:30 AM ISTAstraZeneca said it was planning to supply up to 1,00,000 doses starting toward the end of 2020 and that the U.S. government could acquire up to an...
